Stay updated on ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Sign up to get notified when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The new page shows minor formatting tweaks and small text edits without altering core study information such as eligibility criteria, interventions, outcomes, or listed locations.
    Difference
    0.3%
    Check dated 2025-11-03T01:29:43.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T10:30:31.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a content pruning aligned with a versioned update.
    Difference
    0.2%
    Check dated 2025-09-28T03:20:53.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Page version updated to v3.0.2, replacing the old v3.0.1 reference. The 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:44:10.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T15:28:58.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of new topics related to drug safety and pharmaceutical preparations. Notably, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    3%
    Check dated 2025-08-30T12:18:22.000Z thumbnail image

Stay in the know with updates to ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.